It could promote the migration of pancreatic cancer cells by targetingTable

It could promote the migration of pancreatic cancer cells by targetingTable 2. Univariate and Multivariate Analyses of Different Prognostic Parameters on Breast Cancer Disease-free Survival Rates.Univariate analyses P Age Menopause Histological grade T-stage N-stage ER status PR status Her-2 status miR-27a ZBTB10 0.893 0.915 0.745 0.000 0.016 0.935 0.333 0.055 0.001 0.000 Regression coefficient (SE) 20.05 (0.371) 0.048(0.449) 0.095 (0.291) 1.151(0.292) 0.497(0.207) 20.038(0.463) 0.72(0.744) 0.84(0.437) 1.728(0.513) 21.846(0.485)Multivariate analyses P Relative risk 95 Confidence interval0.3.1.653?.0.054 0.012 0.025 0.4.778 3.373 3.573 0.0.973?3.478 1.300?.750 1.176?0.860 0.089?.(SE) standard error; multivariate analysis; Cox ITI 007 site proportional hazard regression model, stepwise forward LR. doi:10.1371/journal.pone.0051702.tMiR-27a as a Predictor of Invasive Breast CancerTable 3. Univariate and Multivariate Analyses of Overall Survival Rates in Patients with Breast Cancers by Cox-Regression Analysis.Univariate analyses P Age Menopause Histological grade T-stage N-stage ER status PR status Her-2 status miR-27a ZBTB10 0.851 0.872 0.721 0.000 0.016 0.958 0.358 0.028 0.001 0.000 Regression coefficient (SE) 20.068 (0.361) 0.072(0.45) 0.104(0.292) 1.2(0.293) 0.494(0.204) 20.024(0.463) 0.684(0.744) 0.977(0.443) 1.739(0.513) 21.774(0.484)Multivariate analyses P Relative risk 95 Confidence interval0.3.1.645?.0.4.1.665?2.(SE) standard error; multivariate analysis; Cox proportional hazard regression model, stepwise forward LR. doi:10.1371/journal.pone.0051702.tSprouty2 [28] and increase endothelial cell sprouting by regulating the expression of the angiogenesis inhibitor semaphorin 6A (SEMA6A) [29]. In addition, 15481974 miR-27a plays an important role in mediating drug resistance by targeting Lecirelin biological activity multiple drug-resistance related genes. MiR-27a modulated MDR1/P-glycoprotein expression in human ovarian cancer cells by targeting HIPK2 [15] and could reverse the multidrug resistance of esophageal squamous cell carcinoma through regulation of MDR1 and apoptosis [14]. This study focused on the potential relationship between the expression level of miR-27a and various clinicopathological characteristics of breast cancer patients, as well as disease-free survival and overall survival. It is worth noting that high levels of miR-27a appear to be significantly correlated with tumor size, lymph node metastases, distant metastasis and poor prognosis in patients with breast cancer. MiR-27a was up-regulated in patients presenting with metastases, suggesting that its up-regulation was acquired in the course of tumor progression and, in particular, during the acquisition of metastatic potential. Our results showed that miR-27a and ZBTB10 expression were not correlated with receptor status. On the contrary, it was reported that miR-27a indirectly regulates estrogen receptora expression and hormone responsiveness in MCF-7 breast cancer cells through the suppression of ZBTB10 [30]. To understand these conflicting results, the difference between clinical observation and in vitro experiments should be considered. After dividing the patients by the cut-off method, a multivariate Cox proportional hazard regression analysis revealed that miR-27a overexpression had a significantly worse prognostic impact (P = 0.003) on the overall survival of breast cancer patients independent of tumor size (P = 0.000). These results indicate that, as an independent risk factor, miR-27a could serve as a pr.It could promote the migration of pancreatic cancer cells by targetingTable 2. Univariate and Multivariate Analyses of Different Prognostic Parameters on Breast Cancer Disease-free Survival Rates.Univariate analyses P Age Menopause Histological grade T-stage N-stage ER status PR status Her-2 status miR-27a ZBTB10 0.893 0.915 0.745 0.000 0.016 0.935 0.333 0.055 0.001 0.000 Regression coefficient (SE) 20.05 (0.371) 0.048(0.449) 0.095 (0.291) 1.151(0.292) 0.497(0.207) 20.038(0.463) 0.72(0.744) 0.84(0.437) 1.728(0.513) 21.846(0.485)Multivariate analyses P Relative risk 95 Confidence interval0.3.1.653?.0.054 0.012 0.025 0.4.778 3.373 3.573 0.0.973?3.478 1.300?.750 1.176?0.860 0.089?.(SE) standard error; multivariate analysis; Cox proportional hazard regression model, stepwise forward LR. doi:10.1371/journal.pone.0051702.tMiR-27a as a Predictor of Invasive Breast CancerTable 3. Univariate and Multivariate Analyses of Overall Survival Rates in Patients with Breast Cancers by Cox-Regression Analysis.Univariate analyses P Age Menopause Histological grade T-stage N-stage ER status PR status Her-2 status miR-27a ZBTB10 0.851 0.872 0.721 0.000 0.016 0.958 0.358 0.028 0.001 0.000 Regression coefficient (SE) 20.068 (0.361) 0.072(0.45) 0.104(0.292) 1.2(0.293) 0.494(0.204) 20.024(0.463) 0.684(0.744) 0.977(0.443) 1.739(0.513) 21.774(0.484)Multivariate analyses P Relative risk 95 Confidence interval0.3.1.645?.0.4.1.665?2.(SE) standard error; multivariate analysis; Cox proportional hazard regression model, stepwise forward LR. doi:10.1371/journal.pone.0051702.tSprouty2 [28] and increase endothelial cell sprouting by regulating the expression of the angiogenesis inhibitor semaphorin 6A (SEMA6A) [29]. In addition, 15481974 miR-27a plays an important role in mediating drug resistance by targeting multiple drug-resistance related genes. MiR-27a modulated MDR1/P-glycoprotein expression in human ovarian cancer cells by targeting HIPK2 [15] and could reverse the multidrug resistance of esophageal squamous cell carcinoma through regulation of MDR1 and apoptosis [14]. This study focused on the potential relationship between the expression level of miR-27a and various clinicopathological characteristics of breast cancer patients, as well as disease-free survival and overall survival. It is worth noting that high levels of miR-27a appear to be significantly correlated with tumor size, lymph node metastases, distant metastasis and poor prognosis in patients with breast cancer. MiR-27a was up-regulated in patients presenting with metastases, suggesting that its up-regulation was acquired in the course of tumor progression and, in particular, during the acquisition of metastatic potential. Our results showed that miR-27a and ZBTB10 expression were not correlated with receptor status. On the contrary, it was reported that miR-27a indirectly regulates estrogen receptora expression and hormone responsiveness in MCF-7 breast cancer cells through the suppression of ZBTB10 [30]. To understand these conflicting results, the difference between clinical observation and in vitro experiments should be considered. After dividing the patients by the cut-off method, a multivariate Cox proportional hazard regression analysis revealed that miR-27a overexpression had a significantly worse prognostic impact (P = 0.003) on the overall survival of breast cancer patients independent of tumor size (P = 0.000). These results indicate that, as an independent risk factor, miR-27a could serve as a pr.